Targeting proinflammatory mediators to restore treg homeostatic expansion and function in ALS, in vitro studies as surrogates for in vivo applications

Ended Project Grant Awarded Last action

Award ID
W81XWH2110137
Recipient
Awarding agency
Obligated
$895,001

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

Brigham & Women's Hospital Inc. was awarded an $895,001 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award will support in vitro studies targeting proinflammatory mediators to restore regulatory T cell homeostatic expansion and function in amyotrophic lateral sclerosis. The research aims to develop surrogates for in vivo applications in investigating medical solutions for the battlefield and transforming healthcare for service members and the public through innovative biomedical research. The grant will fund laboratory work at Brigham & Women's Hospital in Boston through May 2023 to explore modulating the immune system as a potential treatment approach for ALS.

Quick answers

Who received award W81XWH2110137?

W81XWH2110137 was awarded to Brigham & Womens Hospital Inc. by Medical Command (Department of the Army) on June 1, 2021.

How much is award W81XWH2110137 worth?

$895,001 has been obligated on W81XWH2110137.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login